Grapheal logo — Bringing connectivity to biosensors. Digital biosensors for...

Grapheal

Bringing connectivity to biosensors. Digital biosensors for wearables, diagnostics and wound care.

Founded 2019 France France 8 employees Grant Total: $1.90M Biotechnology, Hardware +4

General Information

Company Name Grapheal
Founded Year 2019
Location France France +1
Employees 8
Industries Biotechnology, Hardware, Health Care +3
Funding Stage Grant
Social

Get notified when Grapheal moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Grapheal

GRAPHEAL is a French biotechnology startup focused on bringing connectivity to biosensors, with a mission to develop digital biosensors for wearables, diagnostics, and wound care. Grapheal is a spin-off from Neel Institute at the French Research Center CNRS in Grenoble, founded in 2019. Leveraging 10 years of research and development on biomaterials fabrication and integration, Grapheal has emerged with the aim of improving chronic wounds medical care through a new generation of smart-bandages. The core technology of Grapheal is centered on the physical and biochemical properties of graphene. It utilizes graphene as a bioactive material, an electrical platform for wound stimulation, and a biodetection platform to monitor real-time healing. The company's smart-bandages offer benefits to both patients and medical staff, as they combine efficient and flexible dressing with a simple smartphone app for monitoring day-to-day wound healing progress. With strong footings in Biotechnology, Hardware, Health Care, IoT, Medical Devices, and Autonomous and Sensor Tech industries, Grapheal received a grant investment from Health Engine on 27 April 2023. This investment marks a significant milestone in the company's journey, strengthening its position in the burgeoning digital biosensors and healthcare technology landscape.

Taxonomy: wearable technology, biosensors, medical assessment, continuous monitoring, individualized care, Grenoble, France, startup, personalized healthcare, diagnosis technology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
27 Apr 2023
Seed Round •••••• 2
Investor Investor
10 Feb 2021
Non Equity Assistance •••••• 1
Investor
21 Oct 2020

Grapheal Alternatives & Competitors

Grapheal vs

Facilitating care through technology

7 employees
Health Care, Information Technology
Grapheal vs
SolasCure
SolasCure United Kingdom

Transforming chronic wound care with a breakthrough wound therapeutic

Grant
17 employees
Biopharma, Biotechnology
Grapheal vs
Tympanogen
Tympanogen United States

Sound design. Transformative care.

Series Unknown
8 employees
Biotechnology, Health Care

FAQ About Grapheal

Bringing connectivity to biosensors. Digital biosensors for wearables, diagnostics and wound care.
Grapheal was founded in 2019.
Grapheal is headquartered in France.
Grapheal operates in the following industries: Biotechnology, Hardware, Health Care, IoT, Medical Devices, Autonomous and Sensor Tech.
Grapheal has approximately 8 employees.
Grapheal has completed 3 funding rounds, raising a total of $1.90M. The latest funding stage is Grant.
Top alternatives and competitors to Grapheal include Seber Medical, SolasCure, Tympanogen, Qubix Medicare Pvt. Ltd., HCE South LLC . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Grapheal and Seber Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Grapheal and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy